APR 15, 2016 07:11 AM PDT

How Healthy Cells Become Cancer's Unwitting Allies

WRITTEN BY: Xuan Pham
In what sounds like an epic fantasy battle between good and evil, researchers at the University of Manchester, UK found that cancer cells don’t act alone, but can coerce healthy cells to join the ‘dark side.’ The power of coercion lays in the mutated version of a cancer driver gene called KRAS, which allows cancer cells to persuade healthy cells to secrete growth signals to enable their uncontrolled proliferation. The study provides new information about how cancer cells affect healthy cells, and how this communication loop could be exploited in future cancer treatments.
 
Communication between cancer cell (left) and healthy cell (right)
 The KRAS gene encodes a protein that’s part of a signaling pathway known as the RAS/MAPK pathway, which is involved in cell division and differentiation. Because of its functions in cell growth, mutations in KRAS are often associated with many types of cancers. In particular, the researchers were interested in pancreatic ductal adenocarcinoma, a form of pancreatic cancer whereby KRAS mutations are found over 90% of the time.
 
Using cells that carry KRAS mutations, the team analyzed the secreted signals from the tumor cells. These signals included growth factors, cytokines, and receptors, which influenced the regulation of nearby cells. In particular, when they looked at the relationship between a healthy cell nearby a tumor cell, the team noticed that healthy cells were persuaded to respond in an unexpected way – they secreted growth factors for the cancer cells’ use. With the signals from the healthy cells, cancer cells doubled the potential of KRAS to become even more malignant.
 
 “What our research underlines is that cancer cells do not drive the growth and spread of tumors alone – they can bully their healthy neighbors into helping them,” said Chris Tape, Sir Henry Wellcome Research Fellow at the Institute of Cancer Research, and first study author.
 
 

The cells susceptible to the cancer cells’ influence were stromal cells, which include fat and connective cells that provide structural support for tissues and organs. The communication loop between cancer cells and stromal cells effectively coerces these healthy cells to become cancer’s unwitting allies.
 
And knowing how this happens could be key to finding new drug targets. “Some pancreatic tumors have more healthy stromal cells within them than they do cancer cells, so understanding how cancer cells turn their neighbors into allies is critically important. We have discovered exactly how cancer cells can persuade stromal tissue to secrete key growth signals, and in doing so opened up exciting new possibilities for treatment," said Tape. 

Additional source: ICR UK, MNT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUN 05, 2018
Cell & Molecular Biology
JUN 05, 2018
Mechanism of Aspirin's Anti-Colon Cancer Effects Revealed
For some people, aspirin can help prevent colon cancer; now researchers have learned more about how that happens....
JUN 13, 2018
Cancer
JUN 13, 2018
Tailored vaccine boosts survival for some brain cancer patients
In a new multicenter clinical trial, a personalized vaccine improved the survival rates of some people with the deadly brain cancer glioblastoma. Currently...
JUL 17, 2018
Cancer
JUL 17, 2018
New Small Cell Lung Cancer Subtype Identified
A new subtype of small cell lung cancer is reported to account for potentially 20% of small cell lung cancers diagnosed; it has unique molecular biomarkers and regulatory mechanisms....
JUL 18, 2018
Immunology
JUL 18, 2018
Immunotherapy Increases Survival of Melanoma Brain Metastases Patients
Use of Checkpoint Blockade Immunotherapy increases survival rates in Melanoma Brain Metastases patients, with a 4-year survival rate increase from 11.1% to 28.1%...
AUG 10, 2018
Immunology
AUG 10, 2018
Cancer Cell 'Drones' Battle Immune System
Cancer cells release PD-L1 containing exosomes that circulate in the blood and stop T cells before they can reach tumors....
AUG 14, 2018
Cancer
AUG 14, 2018
New Drug for Refractory Cutaneous T-cell Lymphoma
Mogamulizumab was approved by the FDA this month after a very successful Phase III clinical trial demonstrating its effectiveness in treating patients with challenging CTCL....
Loading Comments...